Intravenous levodopa in hallucinating PD patients

Neurology. 1999 Jan 1;52(1):219-20. doi: 10.1212/wnl.52.1.214-e.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antiparkinson Agents / administration & dosage
  • Antiparkinson Agents / adverse effects*
  • Hallucinations / chemically induced*
  • Humans
  • Injections, Intravenous
  • Levodopa / administration & dosage
  • Levodopa / adverse effects*
  • Parkinson Disease / drug therapy*

Substances

  • Antiparkinson Agents
  • Levodopa